Lunit: AI-powered cancer screening solutions have been selected for Seha Virtual Hospital's AI evaluation and clinical integration project Successful validation to be followed by supply contract to assist Saudi Arabia's national...

NIJMEGEN, Netherlands--(BUSINESS WIRE)--Aiosyn, a medical software company specializing in AI-powered pathology solutions, released its first AI algorithm in its Mitosis product family: Aiosyn Mitosis Research. The innovative deep-learning...

England’s first Integrated Pathology Unit focusing on clinical trial research will use novel technology to diagnose cancer faster and more affordably. England’s first centre of its kind is set to make significant improvements in cancer...

FRANKFURT, May 10 (Reuters) - Scientific journal Nature on Wednesday said a personalised treatment based on messenger RNA by BioNTech (22UAy.DE) potentially bodes well for the future of fighting an extremely aggressive form of cancer after the...

PathAI: Latest research underscores advantages of digital tools at scale to enhance tumor microenvironment and biomarker understanding in non-small cell lung cancer and renal cell carcinoma BOSTON, Mass., April 11, 2023 /PRNewswire/...

PathAI PathExplore™ panel will empower oncology drug developers with improved tumor microenvironment spatial characterization from H&E, propelling a new phase of precision medicine. BOSTON, April 4, 2023 /PRNewswire/ -- PathAI, a...